Shandong Shanda Wit Science and Technology Co Ltd Asset Resilience Ratio
Shandong Shanda Wit Science and Technology Co Ltd asset resilience ratio. Shandong Shanda Wit Science and Technology Co Ltd (000915) has an Asset Resilience Ratio of 25.22% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000915 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Shandong Shanda Wit Science and Technology Co Ltd (1999–2024)
Asset resilience ratio of Shandong Shanda Wit Science and Technology Co Ltd from 1999 to 2024. This chart shows how Shandong Shanda Wit Science and Technology Co Ltd's Asset Resilience Ratio has changed over time. Read Shandong Shanda Wit Science and Technolo debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Shandong Shanda Wit Science and Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shandong Shanda Wit Science and Technolo assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥1.21 Billion | 25.22% |
| Total Liquid Assets | CN¥1.21 Billion | 25.22% |
Asset Resilience Insights
- Very High Liquidity: Shandong Shanda Wit Science and Technology Co Ltd maintains exceptional liquid asset reserves at 25.22% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Shandong Shanda Wit Science and Technology Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shandong Shanda Wit Science and Technology Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Shandong Shanda Wit Science and Technology Co Ltd Asset Resilience Ratio by Year (1999–2024)
Shandong Shanda Wit Science and Technology Co Ltd asset resilience ratio by year from 1999 to 2024. The table below shows the annual Asset Resilience Ratio data for Shandong Shanda Wit Science and Technology Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 19.47% | CN¥960.04 Million ≈ $140.48 Million |
CN¥4.93 Billion ≈ $721.55 Million |
-3.88pp |
| 2023-12-31 | 23.35% | CN¥1.21 Billion ≈ $177.65 Million |
CN¥5.20 Billion ≈ $760.67 Million |
+3.13pp |
| 2022-12-31 | 20.23% | CN¥948.85 Million ≈ $138.85 Million |
CN¥4.69 Billion ≈ $686.37 Million |
+1.89pp |
| 2021-12-31 | 18.34% | CN¥721.61 Million ≈ $105.59 Million |
CN¥3.94 Billion ≈ $575.88 Million |
+17.51pp |
| 2019-12-31 | 0.82% | CN¥26.00 Million ≈ $3.80 Million |
CN¥3.15 Billion ≈ $461.30 Million |
+0.77pp |
| 2016-12-31 | 0.06% | CN¥1.43 Million ≈ $209.78K |
CN¥2.48 Billion ≈ $363.23 Million |
+0.04pp |
| 2005-12-31 | 0.02% | CN¥148.10K ≈ $21.67K |
CN¥952.21 Million ≈ $139.34 Million |
0.00pp |
| 2004-12-31 | 0.02% | CN¥150.00K ≈ $21.95K |
CN¥755.44 Million ≈ $110.54 Million |
0.00pp |
| 2003-12-31 | 0.02% | CN¥150.00K ≈ $21.95K |
CN¥715.07 Million ≈ $104.64 Million |
-5.22pp |
| 2001-12-31 | 5.24% | CN¥25.36 Million ≈ $3.71 Million |
CN¥484.25 Million ≈ $70.86 Million |
-1.69pp |
| 2000-12-31 | 6.93% | CN¥27.68 Million ≈ $4.05 Million |
CN¥399.55 Million ≈ $58.47 Million |
-1.14pp |
| 1999-12-31 | 8.07% | CN¥29.89 Million ≈ $4.37 Million |
CN¥370.30 Million ≈ $54.19 Million |
-- |
About Shandong Shanda Wit Science and Technology Co Ltd
Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration s… Read more